Human Touch Behavioral Health has announced the official launch of its new intravenous ketamine therapy service, a medical treatment now available to patients dealing with depression, anxiety, PTSD, ...

NRx Pharmaceuticals (NASDAQ: NRXP) has filed for the newly launched FDA Commissioner's National Priority Voucher (CNPV) program, seeking accelerated ...

Compass Pathways said on Monday its experimental psilocybin-based therapy helped significantly reduce symptoms of difficult-to-treat depression in a late-stage study.

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

Inside the dimly lit structure, they uncovered drums of chemicals, sophisticated lab equipment stained with residue and crude ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

Farrah Abraham may not be a regular part of the Teen Mom sphere anymore, but she still has plenty to say about the time she did spend closely associated with the show, and the unceremonious ways in ...

It's been nearly two years since the singer's young son was diagnosed with neuroblastoma – an aggressive form of infant ...

The music mogul has pleaded not guilty to charges of sex trafficking, racketeering conspiracy and transportation to engage in ...

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

While the longevity industry promotes costly interventions like full-body scans, supplement stacks, and elite wellness ...